Detalus Advisors’s Eli Lilly LLY Stock Holding History

Detalus Advisors’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$776K	Sell	844 -3	-0.4%	-$3.04K	0.18%	68
2025 Q4	$910K	Hold	847	–	–	0.22%	59
2025 Q3	$646K	Buy	847 +9	+1%	+$6.7K	0.17%	72
2025 Q2	$654K	Sell	838 -7	-0.8%	-$5.44K	0.19%	69
2025 Q1	$698K	Buy	845 +37	+5%	+$30.8K	0.22%	64
2024 Q4	$624K	Buy	808 +10	+1%	+$8.28K	0.21%	67
2024 Q3	$707K	Buy	798 +13	+2%	+$11.7K	0.24%	55
2024 Q2	$711K	Buy	785 +256	+48%	+$205K	0.24%	55
2024 Q1	$412K	Hold	529	–	–	0.15%	90
2023 Q4	$308K	Sell	529 -62	-10%	-$36.2K	0.12%	103
2023 Q3	$317K	Hold	591	–	–	0.15%	91
2023 Q2	$277K	Hold	591	–	–	0.12%	109
2023 Q1	$203K	Sell	591 -89	-13%	-$30K	0.1%	130
2022 Q4	$249K	Buy	+680	New	+$241K	0.12%	114
2022 Q3	–	Sell	-741	Closed	-$240K	–	131
2022 Q2	$240K	Hold	741	–	–	0.14%	101
2022 Q1	$212K	Sell	741 -100	-12%	-$25.7K	0.11%	101
2021 Q4	$232K	Buy	+841	New	+$213K	0.11%	108

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Detalus Advisors's LLY Position: Q1 2026 in Review

Detalus Advisors reduced its Eli Lilly (LLY) stake by 0.35% in Q1 2026, selling an estimated $3.04K and leaving 844 shares worth $776K. The position accounts for 0.18% of the portfolio, ranked #68.

Detalus Advisors first reported a position in LLY in Q4 2021 and has held it in 17 quarters since. The position peaked at $910K in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

Detalus Advisors held 844 shares of Eli Lilly worth $776K as of Q1 2026.
Detalus Advisors sold 3 Eli Lilly shares in Q1 2026, an estimated $3.04K.
Eli Lilly made up 0.18% of Detalus Advisors's portfolio in Q1 2026, its #68 holding.
Detalus Advisors first reported a position in Eli Lilly in Q4 2021 and has held it in 17 quarters since.
Detalus Advisors's Eli Lilly position peaked at $910K in Q4 2025.
4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Detalus Advisors's 13F filing for Q1 2026, filed 22 Apr 2026.